International Biomedical Devices

International Biomedical Devices - Companies to Watch - 2015

IBMD is an early-stage medical device company focused in ophthalmology innovations. The company is leading the emerging, non-laser based, precision capsulotomy category through the development of a unique capsulotomy technology. ApertureCTC™ represents a considerable improvement to traditional surgical techniques by ensuring safe and precise capsulotomies and predictable outcomes for patients. www.aperturectc.com

Read More

ClarVista Medical

ClarVista is a privately held, clinical- and commercial-stage ophthalmology device company concentrating solely on the development of the Harmoni modular intraocular lens (IOL) system. While surgical instrumentation and biometry devices have rapidly progressed and improved in the past decade, the fundamental design of the IOL has not. Surgeons (and patients) have, therefore, come to tolerate…

Read More

Mynosys Cellular Devices

Zepto is an innovative disposable device, used in cataract surgery that uses precision pulse technology. The company notes the device is accurate and creates a reproducible capsulotomy that is quick, safe, and affordable. Zepto consists of a silicon suction cup, a nitinol capsulotomy cutting element and an incision finder/push-rod system. The system works by stretching…

Read More

PowerVision

PowerVision has developed “the first true shape-changing, fluid driven intraocular lens (IOL),” CEO Barry Cheskin said. The FluidVision IOL creates a “continuously variable monofocal” where no light is split as is currently the case with multifocal lenses. The lens mimics the eye’s natural accommodative power to transport fluids inside it, which creates the shape change.…

Read More

A Rundown of a Record-setting OIS

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 066″] The Ophthalmology Innovation Summit hit it big in Las Vegas prior to the industry’s American Academy of Ophthalmology Annual Meeting. With close to 1,000 registered attendees, OIS@AAO brought innovators together with both public and private investors as well as corpo-rate leaders of our dynamic sector. OIS Podcast walks through the…

Read More

Transcend Medical

The year 2015 represented a milestone for Transcend Medical – it completed a milestone study and filed a Premarket Approval for a minimally invasive glaucoma surgery (MIGS) device, the CyPass Micro-Stent. The CyPass is a next-generation device designed to enhance aqueous outflow to the suprachoroidal space by being placed in the supraciliary space (an ab…

Read More

Sadri: How MIGS And Other New Tech May Change His Practice

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 058″] Ehsan Sadri, MD, FACS, FAAO discusses the impact MIGS will have on ophthalmology practices and offers his insights on how ophthalmologist will handle pressure from Obamacare and other external forces going forward. Transcript: Tom Salemi: Hi, everyone. This is Tom Salemi. I am the host of the OIS Podcast which…

Read More

Imprimis’ Baum On Disrupting Compound Pharmacies

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 056″] Imprimis Pharmaceuticals is disrupting the compound pharmaceutical industry, a segment of health care that’s undergoing significant regulatory upheaval. The company’s line of ophthalmology drugs could reduce or eliminate the need for post-surgical eye drops. Its approach is drawing support from many, including Dr. Richard Lindstrom, who serves on the company’s…

Read More

ClarVista’s Two-Part Strategy To Premium IOLs

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 053″] CEO Paul McLean and Medical Director Malik Kahook, MD, explain how they’ll bring Harmoni to the IOL market. Podcast Guest Paul McLean Paul McLean is President and CEO of ClarVista Medical. ClarVista Medical is clinical stage, ophthalmic device Start-up Company focused on the development of the HARMONI modular intra-ocular lens…

Read More

CEO Tom Burns Has Even Bigger Plans For Glaukos

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 052″] MIGs leader Glaukos Corp. raised over $100 million in an IPO to expand its already commanding reach in the white hot MIGs Market. Now the company commands a market capitalization close to $1 billion, enriching the venture investors who committed more than $100 million in venture capital to the company.…

Read More

Hear Bausch + Lomb’s Ophthalmology Play Book

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 046″] Bausch + Lomb Surgical’s Andrew Chang Has Big Plans in Ophthalmology Surgical. Podcast Guest Andrew Chang Andrew is the General Manager and Vice President of US Surgical for Bausch + Lomb, a subsidiary of Valeant International. Prior to joining B+L/Valeant, Andrew was the Director of Marketing for OptiMedica/Catalys before it…

Read More

Ophthalmology Lifetime Innovator Award

OIS@ASCRS - 2015 Award Winner - Richard Lindstrom, MD

Richard L. Lindstrom, MD, Founder & Attending Surgeon – Minnesota Eye Consultants Participant: Richard Lindstrom, MD Dr. Lindstrom is a board-certified ophthalmologist and internationally recognized leader in corneal, cataract, refractive and laser surgery. View Full Profile

Read More